See the DrugPatentWatch profile for Pyridostigmine
How does pyridostigmine bromide work in the body?
Pyridostigmine bromide is a reversible inhibitor of acetylcholinesterase (AChE). By blocking the enzyme that breaks down acetylcholine, it increases acetylcholine levels at cholinergic synapses and neuromuscular junctions. This strengthens cholinergic signaling and improves transmission in conditions where acetylcholine signaling is impaired. [1]
What’s the direct mechanism at the neuromuscular junction?
At the neuromuscular junction, acetylcholine normally binds to nicotinic receptors on the muscle end plate to trigger muscle contraction, then is cleared by acetylcholinesterase. Pyridostigmine inhibits AChE, slowing the breakdown of acetylcholine. The result is more acetylcholine available to stimulate nicotinic receptors and a stronger end-plate response. [1]
Why is it used in myasthenia gravis?
In myasthenia gravis, the problem is reduced effectiveness of neuromuscular transmission (commonly due to antibodies that interfere with the acetylcholine receptor). Increasing acetylcholine availability at the junction helps partially overcome that deficit, improving muscle strength and fatigue. Pyridostigmine’s cholinesterase-inhibiting action is the core mechanism behind this therapeutic effect. [1]
Does it work by stimulating receptors directly?
No. Pyridostigmine does not directly activate acetylcholine receptors. Its main action is to inhibit acetylcholinesterase, which indirectly increases acetylcholine concentration where receptors are present. [1]
What happens if acetylcholinesterase is inhibited too much?
If acetylcholinesterase is inhibited excessively, acetylcholine can accumulate, leading to overstimulation of cholinergic pathways (muscarinic and nicotinic effects). This is why dosing is important: the goal is to improve neuromuscular transmission without pushing cholinergic signaling into an “excess” state. [1]
Any key mechanistic distinction versus irreversible AChE inhibitors?
Pyridostigmine is described as a reversible acetylcholinesterase inhibitor. That reversible mechanism contrasts with some irreversible organophosphate inhibitors, which can cause more prolonged AChE suppression. [1]
Sources:
[1] https://www.drugs.com/pyridostigmine.html